ExploreOutcomeProlapse cure
Outcome

Prolapse cure

Also known as: Prolapse cure, symptom bother, quality of life, and health utility at 6 months QoL
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (27)

None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91
None
null

At 6 months, there was no difference between robotic and laparoscopic sacrocolpopexy groups in POPQ measurements, PFDI/PFIQ subscales, recurrent urinary incontinence symptoms, subsequent sling surgery

Effect: null; EQ-5D 0.90 vs 0.91

Size: EQ-5D 0.90 vs 0.91

Papers (1)